A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses.
Van Loy B, Pujol E, Kamata K, Lee XY, Bakirtzoglou N, Van Berwaer R, Vandeput J, Mestdagh C, Persoons L, De Wijngaert B, Goovaerts Q, Noppen S, Jacquemyn M, Ahmadzadeh K, Bernaerts E, Martín-López J, Escriche C, Vanmechelen B, Krasniqi B, Singh AK, Daelemans D, Maes P, Matthys P, Dehaen W, Rozenski J, Das K, Voet A, Vázquez S, Naesens L, Stevaert A.
Van Loy B, et al. Among authors: escriche c.
PLoS Pathog. 2025 Feb 11;21(2):e1012571. doi: 10.1371/journal.ppat.1012571. eCollection 2025 Feb.
PLoS Pathog. 2025.
PMID: 39932973
Free PMC article.